TrialArteriosclerosis, thrombosis, and vascular biology2009

Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor.

David Masson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.